
|Videos|March 25, 2022
Considerations for Moderna's move to get an EUA for the COVID-19 vaccine in young kids
Author(s)Miranda Hester
Editorial board member Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN, discusses the recently release topline data, the potential timeline, and what potential stumbling blocks could be.
Advertisement
Editorial board member Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN, discusses the recently release topline data, the potential timeline, and what potential stumbling blocks could be.
Newsletter
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Phase 3 trial meets primary endpoint for VIASKIN Peanut patch in children aged 4–7 years
2
Special Report: Rethinking type 1 diabetes through a screening lense
3
19-year-old female with painful, purpuric nodules in the phalanges of her fingers
4
Special Report: Type 1 diabetes and the concept of remission
5








